Key facts
- Notable investors include Balgrist Beteiligungs, Balgrist University Hospital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Artonis
- ·The full record, as it builds
Funding rounds
No funding rounds for Artonis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Artonis
Operator of a biomedical material science company intended to revolutionize orthopedic surgery by providing innovative medical products that enhance minimally invasive techniques. The company offers specialized services for hemostasis, spinal disc repair and cartilage regeneration based on cutting-edge biopolymer chemistry and nanotechnology, enabling customers to improve surgical outcomes, shorten patient recovery times and minimize intraoperative risks.
- Sector
- Healthcare
- HQ
- Zürich, Switzerland
- Founded
- 2025
- Employees
- 3
- Website
- artonis.ch/
- Ownership
- Privately Held (backing)
Artonis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Artonis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Artonis in its N-PORT filings yet. We sweep new filings monthly.